Exon first nucleotide mutations in splicing: Evaluation of in silico prediction tools

PLoS ONE

Volumn 9, Issue 2, 2014, Pages

  Grodecká, Lucie ^a,b   Lockerová, Pavla ^a   Ravčuková, Barbora ^a   Buratti, Emanuele ^c   Baralle, Francisco E ^c   Dušek, Ladislav ^b   Freiberger, Tomáš ^a,b,d  

^a Centre for Cardiovascular Surgery and Transplantation   (Czech Republic)

^b MASARYK UNIVERSITY   (Czech Republic)

^c INTERNATIONAL CENTRE FOR GENETIC ENGINEERING AND BIOTECHNOLOGY   (Italy)

^d ST ANNE S UNIVERSITY HOSPITAL   (Czech Republic)

Author keywords

[No Author keywords available]

Indexed keywords

BRUTON TYROSINE KINASE; POLYPYRIMIDINE TRACT BINDING PROTEIN;

AMINO ACID SUBSTITUTION; ARTICLE; BIOINFORMATICS; COMPUTER MODEL; COMPUTER PREDICTION; CONTROLLED STUDY; EXON; GENE MUTATION; HUMAN; HUMAN CELL; IN VITRO STUDY; MATHEMATICAL COMPUTING; MAXIMUM ENTROPY MODEL; POSITION WEIGHT MATRIX; RNA SPLICING; RNA STRUCTURE; SENSITIVITY AND SPECIFICITY;

AGAMMAGLOBULINEMIA; COMPUTER SIMULATION; EXONS; GENETIC DISEASES, X-LINKED; HELA CELLS; HUMANS; MODELS, GENETIC; MOLECULAR SEQUENCE DATA; POINT MUTATION; PROTEIN-TYROSINE KINASES; RNA SPLICE SITES; RNA SPLICING; SEQUENCE ANALYSIS, DNA; SOFTWARE;

EID: 84896116359     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0089570     Document Type: Article

References (42)

1. Hastings ML, Krainer AR (2001) Pre-mRNA splicing in the new millennium. Curr Opin Cell Biol 13: 302-309. (Pubitemid 32429494)
2. Baralle D, Baralle M (2005) Splicing in action: assessing disease causing sequence changes. J Med Genet 42: 737-748. (Pubitemid 41475248)
3. Fu Y, Masuda A, Ito M, Shinmi J, Ohno K (2011) AG-dependent 3′-splice sites are predisposed to aberrant splicing due to a mutation at the first nucleotide of an exon. Nucleic Acids Res 39: 4396-4404.
4. Reed R (1989) The organization of 3′ splice-site sequences in mammalian introns. Genes Dev 3: 2113-2123.
5. Guth S, Martínez C, Gaur RK, Valcárcel J (1999) Evidence for substrate-specific requirement of the splicing factor U2AF(35) and for its function after polypyrimidine tract recognition by U2AF(65). Mol Cell Biol 19: 8263-8271. (Pubitemid 30414020)
6. Wu S, Romfo CM, Nilsen TW, Green MR (1999) Functional recognition of the 3′ splice site AG by the splicing factor U2AF35. Nature 402: 832-835.
7. Shapiro MB, Senapathy P (1987) RNA splice junctions of different classes of eukaryotes: sequence statistics and functional implications in gene expression. Nucleic Acids Res 15: 7155-7174.
8. Reese MG, Eeckman FH, Kulp D, Haussler D (1997) Improved splice site detection in Genie. J Comput Biol 4: 311-323. (Pubitemid 27355870)
9. Yeo G, Burge CB (2004) Maximum entropy modeling of short sequence motifs with applications to RNA splicing signals. J Comput Biol 11: 377-394. (Pubitemid 38901668)
10. Kol G, Lev-Maor G, Ast G (2005) Human-mouse comparative analysis reveals that branch-site plasticity contributes to splicing regulation. Hum Mol Genet 14: 1559-1568. (Pubitemid 40823463)
11. Schwartz SH, Silva J, Burstein D, Pupko T, Eyras E, et al. (2008) Large-scale comparative analysis of splicing signals and their corresponding splicing factors in eukaryotes. Genome Res 18: 88-103.
12. Fairbrother WG, Yeh RF, Sharp PA, Burge CB (2002) Predictive identification of exonic splicing enhancers in human genes. Science 297: 1007-1013. (Pubitemid 34856033)
13. Zhang XH, Chasin LA (2004) Computational definition of sequence motifs governing constitutive exon splicing. Genes Dev 18: 1241-1250. (Pubitemid 38720592)
14. Cartegni L, Wang J, Zhu Z, Zhang MQ, Krainer AR (2003) ESEfinder: A web resource to identify exonic splicing enhancers. Nucleic Acids Res 31: 3568-3571. (Pubitemid 37442199)
15. Wang Z, Rolish ME, Yeo G, Tung V, Mawson M, et al. (2004) Systematic identification and analysis of exonic splicing silencers. Cell 119: 831-845. (Pubitemid 40017689)
16. Schwartz S, Hall E, Ast G (2009) SROOGLE: webserver for integrative, user-friendly visualization of splicing signals. Nucleic Acids Res 37: W189-192.
17. Sickmier EA, Frato KE, Shen H, Paranawithana SR, Green MR, et al. (2006) Structural basis for polypyrimidine tract recognition by the essential pre-mRNA splicing factor U2AF65. Mol Cell 23: 49-59. (Pubitemid 43963446)
18. Mackereth CD, Madl T, Bonnal S, Simon B, Zanier K, et al. (2011) Multidomain conformational selection underlies pre-mRNA splicing regulation by U2AF. Nature 475: 408-411.
19. Jenkins JL, Agrawal AA, Gupta A, Green MR, Kielkopf CL (2013) U2AF65 adapts to diverse pre-mRNA splice sites through conformational selection of specific and promiscuous RNA recognition motifs. Nucleic Acids Res 41: 3859-3873.
20. Graveley BR, Hertel KJ, Maniatis T (1998) A systematic analysis of the factors that determine the strength of pre-mRNA splicing enhancers. EMBO J 17: 6747-6756. (Pubitemid 28521808)
21. Doktor TK, Schroeder LD, Vested A, Palmfeldt J, Andersen HS, et al. (2011) SMN2 exon 7 splicing is inhibited by binding of hnRNP A1 to a common ESS motif that spans the 3′ splice site. Hum Mutat 32: 220-230.
22. Roscigno RF, Weiner M, Garcia-Blanco MA (1993) A mutational analysis of the polypyrimidine tract of introns. Effects of sequence differences in pyrimidine tracts on splicing. J Biol Chem 268: 11222-11229. (Pubitemid 23162315)
23. Coolidge CJ, Seely RJ, Patton JG (1997) Functional analysis of the polypyrimidine tract in pre-mRNA splicing. Nucleic Acids Res 25: 888-896.
24. Chen M, Manley JL (2009) Mechanisms of alternative splicing regulation: insights from molecular and genomics approaches. Nat Rev Mol Cell Biol 10: 741-754.
25. Spellman R, Smith CW (2006) Novel modes of splicing repression by PTB. Trends Biochem Sci 31: 73-76. (Pubitemid 43221838)
26. Graveley BR, Hertel KJ, Maniatis T (2001) The role of U2AF35 and U2AF65 in enhancer-dependent splicing. RNA 7: 806-818. (Pubitemid 32552869)
27. Zhang WJ, Wu JY (1996) Functional properties of p54, a novel SR protein active in constitutive and alternative splicing. Mol Cell Biol 16: 5400-5408.
28. Shen H, Green MR (2004) A pathway of sequential arginine-serine-rich domainsplicing signal interactions during mammalian spliceosome assembly. Mol Cell 16: 363-373. (Pubitemid 39504791)
29. Pacheco TR, Coelho MB, Desterro JM, Mollet I, Carmo-Fonseca M (2006) In vivo requirement of the small subunit of U2AF for recognition of a weak 39 splice site. Mol Cell Biol 26: 8183-8190. (Pubitemid 44637099)
30. Shen H, Kan JL, Green MR (2004) Arginine-serine-rich domains bound at splicing enhancers contact the branchpoint to promote prespliceosome assembly. Mol Cell 13: 367-376. (Pubitemid 38229809)
31. Bennett M, Michaud S, Kingston J, Reed R (1992) Protein components specifically associated with prespliceosome and spliceosome complexes. Genes Dev 6: 1986-2000.
32. Cartegni L, Chew SL, Krainer AR (2002) Listening to silence and understanding nonsense: exonic mutations that affect splicing. Nat Rev Genet 3: 285-298. (Pubitemid 34279797)
33. Shariat N, Holladay CD, Cleary RK, Phillips JA, Patton JG (2008) Isolated growth hormone deficiency type II caused by a point mutation that alters both splice site strength and splicing enhancer function. Clin Genet 74: 539-545.
34. Gaildrat P, Krieger S, Di Giacomo D, Abdat J, Révillion F, et al. (2012) Multiple sequence variants of BRCA2 exon 7 alter splicing regulation. J Med Genet 49: 609-617.
35. Auclair J, Busine MP, Navarro C, Ruano E, Montmain G, et al. (2006) Systematic mRNA analysis for the effect of MLH1 and MSH2 missense and silent mutations on aberrant splicing. Hum Mutat 27: 145-154. (Pubitemid 43238030)
36. Lastella P, Surdo NC, Resta N, Guanti G, Stella A (2006) In silico and in vivo splicing analysis of MLH1 and MSH2 missense mutations shows exon- and tissue-specific effects. BMC Genomics 7: 243.
37. Vorechovský I (2006) Aberrant 3′ splice sites in human disease genes: mutation pattern, nucleotide structure and comparison of computational tools that predict their utilization. Nucleic Acids Res 34: 4630-4641.
38. Buratti E, Chivers M, Královicová J, Romano M, Baralle M, et al. (2007) Aberrant 5′ splice sites in human disease genes: mutation pattern, nucleotide structure and comparison of computational tools that predict their utilization. Nucleic Acids Res 35: 4250-4263. (Pubitemid 47260233)
39. Abovich N, Rosbash M (1997) Cross-intron bridging interactions in the yeast commitment complex are conserved in mammals. Cell 89: 403-412. (Pubitemid 27220885)
40. Berglund JA, Abovich N, Rosbash M (1998) A cooperative interaction between U2AF65 and mBBP/SF1 facilitates branchpoint region recognition. Genes Dev 12: 858-867. (Pubitemid 28150886)
41. Houdayer C, Dehainault C, Mattler C, Michaux D, Caux-Moncoutier V, et al. (2008) Evaluation of in silico splice tools for decision-making in molecular diagnosis. Hum Mutat 29: 975-982. (Pubitemid 351951292)
42. Zampieri S, Buratti E, Dominissini S, Montalvo AL, Pittis MG, et al. (2011) Splicing mutations in glycogen-storage disease type II: evaluation of the full spectrum of mutations and their relation to patients' phenotypes. Eur J Hum Genet 19: 422-431.